abstract |
Thiazole derivatives of formula I are provided as well as pharmaceutically acceptable salts and esters thereof, wherein R<SUP>1 </SUP>to R<SUP>5</SUP>, a and b have the significance given in the specification. The compounds are neuropeptide Y Y5 receptor antagonists which can be used for the treatment of obesity. |